Keywords: IPF; idiopathic pulmonary fibrosis; AEC; alveolar epithelial cell; TGF-β; transforming growth factor; CTGF; connective tissue growth factor; Shh; sonic hedgehog; PGE2; prostaglandin E2; ROS; reactive oxygen species; H2O2; hydrogen peroxide; Pulmonary fib
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: AEC; alveolar epithelial cell; AT2; alveolar epithelial type II; AM; alveolar macrophage; ARE; antioxidant response element; BALF; bronchoalveolar lavage fluid; JNK; c-Jun N-terminal kinase; EGFR; epidermal growth factor receptor; ECM; extracellular matri
Keywords: epidemiology (pulmonary); interstitial lung disease; mobile health; IPF; idiopathic pulmonary fibrosis; NO2; nitrogen dioxide; O3; ozone; PM2.5; particulate matter < 2.5 μm in aerodynamic diameter; PM10; particulate matter < 10 μm in aerodynamic diame
Keywords: interstitial lung disease; pulmonary fibrosis; smoking; AEC2; type 2 alveolar epithelial cells; AEP; acute eosinophilic pneumonia; CPFE; combined pulmonary fibrosis and emphysema; CTD-ILD; connective tissue disease-related interstitial lung disease; DIP;
Acute exacerbation of idiopathic pulmonary fibrosis triggered by Aspergillus empyema
Keywords: Idiopathic pulmonary fibrosis; Acute exacerbation; AE-IPF; Triggered AE; Aspergillus infection; AE; acute exacerbation; AMPH-B; amphotericin-B; CRP; C-reactive protein; CT; computed tomography; ILD; interstitial lung disease; IPF; idiopathic pulmonary fib
Treatment Rationale and Design for J-SONIC: AÂ Randomized Study of Carboplatin Plus Nab-paclitaxel With or Without Nintedanib for Advanced Non-Small-cell Lung Cancer With Idiopathic Pulmonary Fibrosis
Keywords: Acute exacerbation; Chemotherapy; IPF; NSCLC; Prospective study;
Impact of Treg on other T cell subsets in progression of fibrosis in experimental lung fibrosis
Keywords: BM; bleomycin; BIPF; bleomycin-induced pulmonary fibrosis; IPF; idiopathic pulmonary fibrosis; Treg; regulatory T cell; ROR-γT; retinoid-related orphan receptor γT; IFN-γ; interferon-γ; IL-; interleukin-; BW; body weight; Lung fibrosis; Treg cell; Th1
ILD-NSCLC-GAP index scoring and staging system for patients with non-small cell lung cancer and interstitial lung disease
Keywords: ILD; interstitial lung disease; NSCLC; non-small cell lung cancer; AE; acute exacerbation; IPF; idiopathic pulmonary fibrosis; %FVC; percent predicted forced vital capacity; %DLCO; percent predicted diffusion capacity of lung for carbon monoxide; TKI; tyr
A multicenter, open-label, phase II trial of S-1 plus carboplatin in advanced non-small cell lung cancer patients with interstitial lung disease
Keywords: ILD; interstitial lung disease; IPF; idiopathic pulmonary fibrosis; AE; acute exacerbation; AE-ILD; acute exacerbation of interstitial lung disease; NSCLC; non-small cell lung cancer; S-1; tegafur-gimeracil-oteracil potassium; CBDCA; carboplatin; RECIST;
Advanced processing of EBSD data to distinguish the complex microstructure evolution of a Cu-Ni-Si alloy induced by fatigue
Keywords: ECCI; Electron Channeling Contrast Imaging; Îεt; total strain variation; EBSD; Electron Back-scattered Diffraction; FSE; Forward Scattered Electrons; GOS; Grain Orientation Spread; GROD; Grain Reference Orientation Deviation; IPF; Inverse Pole Figure; I
Physical activity in daily life in patients with idiopathic pulmonary fibrosis
Keywords: AEE; activity energy expenditure; BDI; Baseline Dyspnea Index; BMI; body mass index; COPD; chronic obstructive pulmonary disease; DLco; diffusing capacity of carbon monoxide; FEV1; forced expiratory flow in 1Â s; fIIP; fibrotic idiopathic interstitial pne
Endpoints in sarcoidosis: More like IPF or asthma?
Keywords: Sarcoidosis; Endpoints; IPF; Asthma; Corticosteroids; Quality of life;
The role of TRPV4 in fibrosis
Keywords: α-SMA; α-smooth muscle actin; aa; amino acids; AHF; alcohol/high fat diet; AIP4; atrophin-interacting protein 4; ANK; ankyrin; ARS-L; arachidonate-like recognition sequence; ASL; airway surface liquid; BKCa; Ca2 +-dependent K+; [Ca2 +]i; intracellular
Respiratory comorbidities and risk of mortality in hospitalized patients with idiopathic pulmonary fibrosis
Keywords: IPF; idiopathic pulmonary fibrosis; GAP score; gender, age, and physiology variables score; JRS; Japanese Respiratory Society; DPC/PDPS; diagnosis procedure combination/per-diem payment system; ICD-10; International Classification of Diseases and Related
Severe idiopathic pulmonary fibrosis: A clinical approach
Keywords: IPF; idiopathic pulmonary fibrosis; UIP; Usual Interstitial Pneumonia; FVC; Forced Vital Capacity; SVC; Slow Vital Capacity; FEV1; Forced Expiratory Volume in the first second; TLC; Total Lung Capacity; RV; Residual Volume; DLCO; Diffusing Capacity of the
Is hypothyroidism in idiopathic pleuroparenchymal fibroelastosis a novel lung-thyroid syndrome?
Keywords: BMI; body mass index; FVC; forced vital capacity; HRCT; high-resolution computed tomography; HypoT; hypothyroidism; IPF; idiopathic pulmonary fibrosis; IPPFE; idiopathic pleuroparenchymal fibroelastosis; KL-6; Krebs von den Lungen-6; NTI; nonthyroidal ill
Pro-fibrotic phenotype of human skin fibroblasts induced by periostin via modulating TGF-β signaling
Keywords: ECM; extracellular matrix; SSc; systemic sclerosis; TGF-β; transforming growth factor-β; rPn; recombinant periostin; α-SMA; α -smooth muscle actin; Egr-1; early growth response-1; MMP; matrix metalloproteinase; IPF; idiopathic pulmonary fibrosis; R-Sm
Microstructural hardness heterogeneity triggers fatigue crack non-propagation in as-hot-rolled Fe-30Mn-3Si-3Al twinning-induced plasticity steel
Keywords: Fatigue limit; Non-propagating fatigue crack; Twinning-induced plasticity steel; Hardness heterogeneity; Dugdale model; DSA; dynamic strain aging; EBSD; electron backscattering diffraction; GROD; grain reference orientation deviation; IPF; inverse pole fi
Phenotypic Clusters Predict Outcomes in a Longitudinal Interstitial Lung Disease Cohort
Keywords: cluster; interstitial lung disease; mortality; phenotype; pulmonary fibrosis; ANA; antinuclear antibody; ATS; American Thoracic Society; CHP; chronic hypersensitivity pneumonitis; CTD; connective tissue disease; CTD-ILD; connective tissue disease-associat
Use of animal models in IPF research
Keywords: Animal models; IPF; Preclinical;
BH3 mimetics as anti-fibrotic therapy: Unleashing the mitochondrial pathway of apoptosis in myofibroblasts
Keywords: ECM; extracellular matrix; SSc; systemic sclerosis or scleroderma; IPF; idiopathic pulmonary fibrosis; CKD; chronic kidney disease; α-SMA; alpha-smooth muscle actin; FAK; focal adhesion kinase; ROCK; rho associated protein kinase; BH; BCL-2 homology; MOM
The rs2609255 polymorphism in the FAM13A gene is reproducibly associated with silicosis susceptibility in a Chinese population
Keywords: GWAS; genome-wide association studies; NGS; next-generation sequencing; SNPs; single nucleotide polymorphisms; IIPs; idiopathic interstitial pneumonias; FAM13A; family with sequence similarity 13, member A; IPF; idiopathic pulmonary fibrosis; COPD; chroni
Decreased neutrophil-associated miRNA and increased B-cell associated miRNA expression during tuberculosis
Keywords: M.tb; Mycobacterium tuberculosis; PCR; polymerase chain reaction; TB; tuberculosis; CLL; chronic lymphocytic leukemia; IPF; idiopathic pulmonary fibrosis; HHC; household contact; PBMC; peripheral blood mononuclear cells; RBC; red blood cell; PBS; phosphat
Impact of minor alloying with C and Si on the precipitation behavior and mechanical properties of N-doped Co-Cr alloy dental castings
Keywords: BSE; back-scattered electron; EBSD; electron-backscatter diffraction; EPMA; electron-probe microanalysis; fcc; face-centered cubic; FE-EPMA; field-emission electron-probe microanalysis; FE-SEM; field-emission scanning electron microscopy; HAB; high-angle
The KCa3.1 blocker TRAM-34 inhibits proliferation of fibroblasts in paraquat-induced pulmonary fibrosis
Keywords: PQ; paraquat; TGF-β1; transforming growth factor-β1; IPF; idiopathic pulmonary fibrosis; PBS; phosphate-buffered saline; BALF; bronchoalveolar lavage fluid; PVDF; polyvinylidene fluoride; TBST; Tris-buffered saline with Tween 20; α-SMA; α-smooth muscl
A homologues prediction strategy for comprehensive screening and characterization of C21 steroids from Xiao-ai-ping injection by using ultra high performance liquid chromatography coupled with high resolution hybrid quadrupole-orbitrap mass spectrometry
Keywords: UHPLC-Q-Orbitrap MS; ultra high performance liquid chromatography with high resolution hybrid quadrupole-orbitrap mass spectrometry; HESI; heat electrospray ionization; TCMs; traditional Chinese medicines; Q-TOF-MS; hybrid quadrupole orthogonal time-of-fl
The apparent competitive action of ECM proteases and cross-linking enzymes during fibrosis: Applications to drug discovery
Keywords: ADAMs; a disintegrin and metalloproteinases; ADAMTS; ADAMs with thrombospondin motifs; BALF; bronchoalveolar lavage fluid; BAPN; β-aminopropionitrile; CD; Crohn's disease; ECM; extracellular matrix; EMT; epithelial to mesenchymal transition; EndoMT; endo
Cartilage oligomeric matrix protein: COMPopathies and beyond
Keywords: ATF6; activating transcription factor 6; ATP; adenosine triphosphate; BiP; binding immunoglobulin protein; BMD; bone mineral density; Chop; Mouse c/ebp homologous protein genes; CHOP; c/ebp homologous protein; COL9A1; human collagen type 9 Alpha 1 chain g
Biomarkers in idiopathic pulmonary fibrosis
Keywords: Biomarkers; IPF; MUC5B; Matrix metalloprotease;
Idiopathic pulmonary fibrosis: Epithelial-mesenchymal interactions and emerging therapeutic targets
Keywords: IPF; Genetics; Interstitial lung disease; Matrix; Treatment;
WNT receptor signalling in lung physiology and pathology
Keywords: ABC; active β-catenin/non-phosphorylated β-catenin; APC; adenomatous polyposis coli; ATI; alveolar epithelial type I cell; ATII; alveolar epithelial type II cell; AXIN; axis inhibition protein; CBR2; carbonyl reductase 2; CK1; casein kinase 1; CELSR1; c
Hepatotoxicity of nintedanib in patients with idiopathic pulmonary fibrosis: A single-center experience
Keywords: IPF; idiopathic pulmonary fibrosis; AST; aspartate aminotransferase; ALT; alanine aminotransferase; CTCAE; Common Terminology Criteria for Adverse Events; ULN; upper limit of the normal range; BMI; body mass index; BSA; body surface area; FVC; forced vita
Study of IPF among patients with gastro-esophageal reflux disease
Keywords: IPF; GERD; DLCO;
Direct hemoperfusion with polymyxin B-immobilized fiber for the treatment of the acute exacerbation of idiopathic pulmonary fibrosis in patients requiring invasive mechanical ventilation
Keywords: AE-IPF; acute exacerbation of idiopathic pulmonary fibrosis; ALAT; Latin American Thoracic Association; ATS; American Thoracic Society; BAL; bronchoalveolar lavage; CT; computed tomography; ERS; European Respiratory Society; FVC; forced vital capacity; IP
Simple determination of L-hydroxyproline in idiopathic pulmonary fibrosis lung tissues of rats using non-extractive high-performance liquid chromatography coupled with fluorescence detection after pre-column derivatization with novel synthetic 9-acetylimi
Keywords: AIC; 9-acetylimidazol-carbazole; DABSYL-Cl; dimethylaminoazobenzenesulfonyl chloride; DMAP; 4-dimethylaminopyridine; DMS-Cl; 4-(5,6-dimethoxy-2-phthalimidinyl)-2-methoxyphenylsulfonyl chloride; FMOC-Cl; fluorenylmethyl chloroformate; HPAEC-PAD; high perfo
Trace metals in fluids lining the respiratory system of patients with idiopathic pulmonary fibrosis and diffuse lung diseases
Keywords: IPF; idiopathic pulmonary fibrosis; ILD; interstitial lung diseases; COPD; chronic obstructive pulmonary diseases; CF; cystic fibrosis; PLCH; pulmonary Langerhans cell histiocytosis; BAL; bronchoalveolar lavage; EBC; exhaled breath condensate; TLC; total
Clinical characteristics of patients with anti-aminoacyl-tRNA synthetase antibody positive idiopathic interstitial pneumonia
Keywords: Anti-synthetase syndrome; Idiopathic interstitial pneumonia; Dermatomyositis; Polymyositis; ALD; aldolase; ARS; anti-aminoacyl-tRNA synthetase; ARS(â); anti-ARS antibody negative; ARS(+); anti-ARS antibody positive; ASS; anti-synthetase syndrome; BALF;
NLRP3 participates in the regulation of EMT in bleomycin-induced pulmonary fibrosis
Keywords: IPF; idiopathic pulmonary fibrosis; EMT; epithelial-mesenchymal transition; BLM; bleomycin; NLRP3; NOD-like receptor family, pyrin domain-containing protein 3; ASC; apoptosis-associated speck-like protein containing a CARD; IL-1β; interleukin-1β; IL-18;
Analysis of acute exacerbation of interstitial lung disease associated with chemotherapy in patients with lung cancer: A feasibility of S-1
Keywords: LC; lung cancer; ILD; interstitial lung disease; HRCT; high-resolution computed tomography; AE; acute exacerbation; DAD; diffuse alveolar damage; IPF; idiopathic pulmonary fibrosis; PS; performance status; ECOG; Eastern Cooperative Oncology Group; NSCLC;
Prognostic value of serial serum KL-6 measurements in patients with idiopathic pulmonary fibrosis
Keywords: ALAT; Latin American Thoracic Association; ATS; American Thoracic Society; CT; computed tomography; ERS; European Respiratory Society; FVC; forced vital capacity; GGO; ground glass opacities; IP; interstitial pneumonia; IPF; idiopathic pulmonary fibrosis;
Development of a new ARCHITECT automated periostin immunoassay
Keywords: BGG; bovine gamma globulin; CI; confidence interval; CLSI; Clinical and Laboratory Standards Institute; CV; coefficient of variation; HAMA; human anti-mouse antibodies; Ig; immunoglobulin; IL; interleukin; IPF; idiopathic pulmonary fibrosis; IUO; Investig
Increased levels of prostaglandin Eâmajor urinary metabolite (PGE-MUM) in chronic fibrosing interstitial pneumonia
Keywords: PGE-MUM; Interstitial pneumonia; IPF; PGE-MUM; prostaglandin Eâmajor urinary metabolite; PGE2; prostaglandin E2; IP; interstitial pneumonia; CFIP; chronic fibrosing IP; BA; bronchial asthma; COPD; chronic obstructive pulmonary disease; IPF; idiopathic p
Hypoxia-induced ADAM 17 expression is mediated by RSK1-dependent C/EBPβ activation in human lung fibroblasts
Keywords: ADAM 17; a disintegrin and metalloproteinase 17; C/EBPβ; CCAAT/enhancer-binding protein β; ChIP; chromatin immunoprecipitation; COA; chronic obstructive asthma; CTGF; connective tissue growth factor; ECL; enhanced chemiluminescence; ECM; extracellular m
Immiscible phase filter extraction and equivalent amplification of genotypes 1-6 of hepatitis C RNA: The building blocks for point-of-care diagnosis
Keywords: HCV; hepatitis C virus; GT; genotype; IPF; immiscible phase filter; KF; KingFisher; LOD; limit of detection; IC; internal control; NA; nucleic acid; HCV; Viral load monitoring; RT-qPCR; Sample prep;
Lung fibrosis-associated soluble mediators and bronchoalveolar lavage from idiopathic pulmonary fibrosis patients promote the expression of fibrogenic factors in subepithelial lung myofibroblasts
Keywords: IPF; Idiopathic pulmonary fibrosis; IBD; inflammatory bowel disease; SELM; subepithelial lung myofibroblasts; BALF; bronchoalveolar lavage fluid; TF; tissue factor; TNF-α; Tumor necrosis factor-α; IL-1β; interleukin-1β; TGF-β1; Transforming growth fa
The clinical impact of major comorbidities on idiopathic pulmonary fibrosis
Keywords: ACS; acute coronary syndrome; AE; acute exacerbations; AHI; apnea-hypopnea index; BAL; bronchoalveolar lavage; CAD; coronary artery disease; CI; confidence interval; COPD; chronic obstructive pulmonary disease; CPAP; continuous positive airway pressure; C
Clinical implications of donor age: A single-institution analysis spanning 3Â decades
Keywords: lung transplant; donor age; lung transplant survival; lung transplant mortality; Alpha1; alpha-1 anti-trypsin deficiency; BOS; bronchiolitis obliterans syndrome; CI; confidence interval; COPD; chronic obstructive pulmonary disease; HR; hazard ratio; ICU;
Is personalised medicine the key to heterogeneity in idiopathic pulmonary fibrosis?
Keywords: Matrix; Mesenchymal cells; Autoimmunity; Immune dysregulation; TGFβ; IPF; idiopathic pulmonary fibrosis; IL; interleukin; ILD; interstitial lung disease; UIP; usual interstitial pneumonia; NSIP; non-specific interstitial pneumonia; NAC; N-acetylcysteine;
Clinical and Genetic Associations of Objectively Identified Interstitial Changes in Smokers
Keywords: CT scanning; emphysema; interstitial lung abnormalities; mortality; pulmonary fibrosis; COPDGene; Genetic Epidemiology of COPD; ILA; interstitial lung abnormality; ILD; interstitial lung disease; IPF; idiopathic pulmonary fibrosis; MUC5B; mucin 5B; SGRQ;
Increased deposition of glycosaminoglycans and altered structure of heparan sulfate in idiopathic pulmonary fibrosis
Keywords: IPF; idiopathic pulmonary fibrosis; ECM; extracellular matrix; GAG; glycosaminoglycan; HS; heparan sulfate; CS; chondroitin sulfate; DS; dermatan sulfate; HA; hyaluronan; UA; uronic acid; GlcA; glucuronic acid; IdoA; iduronic acid; GalNAc; N-acetyl-d-gala